Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 164


BCl3 -Induced Annulative Oxo- and Thioboration for the Formation of C3-Borylated Benzofurans and Benzothiophenes.

Warner AJ, Churn A, McGough JS, Ingleson MJ.

Angew Chem Int Ed Engl. 2016 Nov 29. doi: 10.1002/anie.201610014. [Epub ahead of print]


New Insights From the MTA: Who Outgrows Attention-Deficit/Hyperactivity Disorder and What Becomes of Those Who Don't?

McGough JJ.

J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):925-926. doi: 10.1016/j.jaac.2016.07.775. No abstract available.


Treatment Controversies in Adult ADHD.

McGough JJ.

Am J Psychiatry. 2016 Oct 1;173(10):960-966. No abstract available.


Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.

Sayer GR, McGough JJ, Levitt J, Cowen J, Sturm A, Castelo E, McCracken JT.

J Child Adolesc Psychopharmacol. 2016 Aug 2. [Epub ahead of print]


Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.

Loo SK, Bilder RM, Cho AL, Sturm A, Cowen J, Walshaw P, Levitt J, Del'Homme M, Piacentini J, McGough JJ, McCracken JT.

J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):674-682.e1. doi: 10.1016/j.jaac.2016.04.020.


Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.

Bilder RM, Loo SK, McGough JJ, Whelan F, Hellemann G, Sugar C, Del'Homme M, Sturm A, Cowen J, Hanada G, McCracken JT.

J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):667-73. doi: 10.1016/j.jaac.2016.05.016.


Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.

McCracken JT, McGough JJ, Loo SK, Levitt J, Del'Homme M, Cowen J, Sturm A, Whelan F, Hellemann G, Sugar C, Bilder RM.

J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):657-666.e1. doi: 10.1016/j.jaac.2016.05.015.


A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.

Bearden CE, Hellemann GS, Rosser T, Montojo C, Jonas R, Enrique N, Pacheco L, Hussain SA, Wu JY, Ho JS, McGough JJ, Sugar CA, Silva AJ.

Ann Clin Transl Neurol. 2016 Feb 22;3(4):266-79. doi: 10.1002/acn3.288.


Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.

Vitiello B, Lazzaretto D, Yershova K, Abikoff H, Paykina N, McCracken JT, McGough JJ, Kollins SH, Greenhill LL, Wigal S, Wigal T, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 2015 Jul;54(7):550-6. doi: 10.1016/j.jaac.2015.04.004.


A parietal biomarker for ADHD liability: as predicted by the distributed effects perspective model of ADHD.

Hale TS, Wiley JF, Smalley SL, Tung KL, Kaminsky O, McGough JJ, Jaini AM, Loo SK.

Front Psychiatry. 2015 May 7;6:63. doi: 10.3389/fpsyt.2015.00063.


Neuropsychological and dimensional behavioral trait profiles in Costa Rican ADHD sib pairs: Potential intermediate phenotypes for genetic studies.

Peskin VA, Ordóñez A, Mackin RS, Delucchi K, Monge S, McGough JJ, Chavira DA, Berrocal M, Cheung E, Fournier E, Badner JA, Herrera LD, Mathews CA.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jun;168B(4):247-57. doi: 10.1002/ajmg.b.32305.


Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder.

Maier R, Moser G, Chen GB, Ripke S; Cross-Disorder Working Group of the Psychiatric Genomics Consortium., Coryell W, Potash JB, Scheftner WA, Shi J, Weissman MM, Hultman CM, Landén M, Levinson DF, Kendler KS, Smoller JW, Wray NR, Lee SH.

Am J Hum Genet. 2015 Feb 5;96(2):283-94. doi: 10.1016/j.ajhg.2014.12.006.


Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways.

Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium..

Nat Neurosci. 2015 Feb;18(2):199-209. doi: 10.1038/nn.3922. Erratum in: Nat Neurosci. 2015 Jun;18(6):926. Nat Neurosci. 2015 Dec;18(12):1861.


An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder.

McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA.

Brain Stimul. 2015 Mar-Apr;8(2):299-304. doi: 10.1016/j.brs.2014.11.013.


Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).

Fernández de la Cruz L, Simonoff E, McGough JJ, Halperin JM, Arnold LE, Stringaris A.

J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):62-70.e3. doi: 10.1016/j.jaac.2014.10.006.


Abnormal Parietal Brain Function in ADHD: Replication and Extension of Previous EEG Beta Asymmetry Findings.

Hale TS, Kane AM, Tung KL, Kaminsky O, McGough JJ, Hanada G, Loo SK.

Front Psychiatry. 2014 Jul 24;5:87. doi: 10.3389/fpsyt.2014.00087.


Visual Network Asymmetry and Default Mode Network Function in ADHD: An fMRI Study.

Hale TS, Kane AM, Kaminsky O, Tung KL, Wiley JF, McGough JJ, Loo SK, Kaplan JT.

Front Psychiatry. 2014 Jul 15;5:81. doi: 10.3389/fpsyt.2014.00081.


Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.

Fleisher C, McGough J.

Expert Opin Investig Drugs. 2014 Aug;23(8):1157-63. doi: 10.1517/13543784.2014.934806. Review.


Chronic non-episodic irritability in childhood: current and future challenges.

McGough JJ.

Am J Psychiatry. 2014 Jun;171(6):607-10. doi: 10.1176/appi.ajp.2014.14030385. No abstract available.


Exposure to neurotoxicants and the development of attention deficit hyperactivity disorder and its related behaviors in childhood.

Yolton K, Cornelius M, Ornoy A, McGough J, Makris S, Schantz S.

Neurotoxicol Teratol. 2014 Jul-Aug;44:30-45. doi: 10.1016/ Review.

Items per page

Supplemental Content

Loading ...
Support Center